Applied DNA Sciences, Inc.

PRESS RELEASE

published on 06/20/2024 at 15:15, 5 months 2 days ago

Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics
Applied DNA and Alphazyme announce successful conclusion of Linea RNAP manufacturing scale-up agreement, resulting in over 70% cost reduction and sufficient quantity for near-term demand. Partnership enhances Linea IVT platform profitability

Biotechnology MRNA Production Alphazyme Linea RNAP Applied DNA
BRIEF

published on 06/18/2024 at 15:05, 5 months 4 days ago

Applied DNA s'associe à GenXys pour l'aide à la décision clinique dans les tests PGx

ADN Appliqué TR8 PGx Tests Pharmacogénomiques GenXys Prescription De Précision
BRIEF

published on 06/18/2024 at 15:05, 5 months 4 days ago

Applied DNA Partners with GenXys for Clinical Decision Support in PGx Testing

Applied DNA Pharmacogenomic Testing TR8 PGx GenXys Precision Prescribing
PRESS RELEASE

published on 06/18/2024 at 15:00, 5 months 4 days ago

Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing
Applied DNA partners with GenXys Health Care Systems to enhance precision prescribing decisions through TR8 PGx test. The partnership aims to improve patient outcomes and reduce healthcare costs

Healthcare Applied DNA Precision Prescribing GenXys Health Care Systems PGx Test
BRIEF

published on 06/13/2024 at 15:05, 5 months 9 days ago

Applied DNA reçoit l'approbation du service de tests pharmacogénomiques TR8™ du ministère de la Santé de l'État de New York

Soins De Santé Sciences Appliquées De L'ADN TR8 PGx Tests Pharmacogénomiques État De New York
BRIEF

published on 06/13/2024 at 15:05, 5 months 9 days ago

Applied DNA Receives Approval for TR8™ Pharmacogenomic Testing Service from New York State Department of Health

New York State Healthcare Applied DNA Sciences Pharmacogenomic Testing TR8 PGx
PRESS RELEASE

published on 06/13/2024 at 15:00, 5 months 9 days ago

Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of Health
Applied DNA Sciences, Inc. receives approval from NYSDOH for TR8 PGx testing service targeting enterprise customers and healthcare networks in New York State, offering personalized medication guidance based on genetic testing

Applied DNA Sciences Personalized Medicine Pharmacogenomic Testing TR8 PGx New York State Department Of Health
BRIEF

published on 06/05/2024 at 15:05, 5 months 17 days ago

Applied DNA Receives Notice of Allowance for Key U.S. Patent

Patent MRNA Production Linea IVT Applied DNA RNA Polymerase
BRIEF

published on 06/05/2024 at 15:05, 5 months 17 days ago

Applied DNA reçoit un avis d'acceptation pour un brevet américain clé

Brevet Production D'ARNm ADN Appliqué Ligne IVT ARN Polymérase
PRESS RELEASE

published on 06/05/2024 at 15:00, 5 months 17 days ago

Applied DNA Announces Notice of Allowance for U.S. Patent Covering Fundamental Aspect of its Linea(TM) IVT Platform
Applied DNA Sciences, Inc. receives Notice of Allowance for patent covering Linea™ RNAP composition empowering Linea™ IVT Platform. Patent protection extends to 2041

Patent MRNA Production Applied DNA Sciences Inc. Linea™ RNAP Linea™ IVT Platform

Published on 11/22/2024 at 23:55, 11 hours 24 minutes ago

Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 11 hours 49 minutes ago

Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 12 hours 14 minutes ago

Kidoz Inc. Announces Results of 2024 AGM
Published on 11/22/2024 at 23:05, 12 hours 14 minutes ago

Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 12 hours 49 minutes ago

Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.

View all ACCESSWIRE

Published on 11/22/2024 at 18:14, 17 hours 4 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 18:00, 17 hours 19 minutes ago

Holding(s) in Company
Published on 11/22/2024 at 17:53, 17 hours 26 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 18 hours 24 minutes ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 19 hours 19 minutes ago

Proposed cancellation of admission to trading

View all EQS

Published on 11/22/2024 at 17:45, 17 hours 34 minutes ago

IMMERSION : RFA 2023/2024
Published on 11/22/2024 at 16:15, 19 hours 4 minutes ago

NRJ GROUP - Le Conseil d'Etat rejette le recours de NRJ 12 et NRJ GROUP
Published on 11/22/2024 at 14:35, 20 hours 44 minutes ago

Communiqué de presse Thales
Published on 11/22/2024 at 14:35, 20 hours 44 minutes ago

Thales Press release
Published on 11/21/2024 at 06:58, 2 days 4 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio

View all LES ECHOS COMFI WIRE

News